Malignant tumors represent one of the most pervasive and formidable challenges to global public health in the modern era. Unlike benign tumors, which are often localized and manageable, malignant neoplasms possess an aggressive capacity for metastasis, posing a direct and existential threat to patients life. Historically, the high mortality rates associated with these diseases are not merely a product of biological virulence, but are significantly driven by the systemic failure of late-stage diagnosis. This crisis is particularly acute in low and lower-middle-income countries (LLMICs), where fragile healthcare infrastructures and limited access to specialized oncological screening often struggle to keep pace with the rapidly rising incidence of the disease. The gravity of this public health emergency is starkly illustrated by recent epidemiological data from Central Asia. In Uzbekistan alone, the year 2022 saw 35,900 new cancer diagnoses and 22,071 recorded deaths, highlighting a devastating mortality-to-incidence ratio. Such figures underscore a critical and immediate urgency for the integration of innovative, scalable diagnostic solutions that can bypass traditional infrastructural bottlenecks. This paper investigates the transformative potential of Artificial Intelligence (AI) as a pivotal tool in bridging the diagnostic gap in resource-constrained environments. By leveraging advanced machine learning algorithms, deep learning for medical imaging, and predictive modeling, AI offers a pathway to democratize high-level oncological expertise. The study explores how these technologies can enhance the precision of early detection specifically in prevalent cases such as breast, stomach, and colorectal cancers thereby reducing human diagnostic error and significantly improving patient survival outcomes. Ultimately, the integration of AI is presented not merely as a technological luxury, but as a fundamental necessity for modernizing cancer care in developing nations.

cancer research, artificial intelligence (AI), oncology, early diagnosis, low-income countries, Uzbekistan, cancer-related deaths, breast cancer, stomach cancer, colorectal cancer, healthcare innovation, machine learning in medicine.

World Health Organization. (2021). Ethics and governance of artificial intelligence for health: WHO guidance. Geneva: World Health Organization. https://www.who.int/publications/i/item/9789240029200

Hunter, B., & Smith, L. (2022). The role of artificial intelligence in early cancer diagnosis. Frontiers in Artificial Intelligence, 5, 857989. https://doi.org/10.3389/frai.2022.857989

WHO Global Observatory on AI for Health. (2023). Market and policy outlook for low- and middle-income countries. Geneva: World Health Organization.

World Health Organization. (2021). State of the global oncology workforce: Regional disparities and challenges. Geneva: World Health Organization.

McKinney, S. M., et al. (Google Health). (2020). International evaluation of an AI system for breast cancer screening. Nature, 577(7788), 89–94. (Google Health tadqiqoti uchun).

Esteva, A., et al. (Stanford University). (2017/2021 update). Dermatologist-level classification of skin cancer with deep neural networks. Nature, 542(7639), 115–118. (Stanford tadqiqoti uchun).

Hunter, B. D., et al. (2025). Artificial intelligence performance in image-based cancer diagnosis: Umbrella review and critical appraisal. Journal of Medical Internet Research, 27, e54321.

Ma, Y., et al. (2025). Artificial intelligence in histopathology: Comprehensive review of algorithms for cancer diagnostics. NPJ Digital Medicine, 8, 115.

Hu, L., et al. (2024). Validation of Automated Visual Evaluation (AVE) for cervical cancer screening using smartphone images. NPJ Digital Medicine, 7, 134.

Tiwari, A., et al. (2025). Current AI technologies in cancer diagnostics and treatment: Clinical translation and future directions. Molecular Cancer, 24(1), 54.

National Cancer Institute. (2019). Researchers create AI approach for cervical cancer screening. U.S. National Institutes of Health.

Desai, K. T., et al. (2021). Development of automated visual evaluation for cervical cancer screening using deep learning. The Lancet Digital Health, 3(6), e360–e371.

Imperial College London & DeepMind. (2022). AI systems in early lung cancer detection: Clinical performance report.

Poli, U. R., et al. (2024). Development and validation of VIA-AI: An automated image-based tool for cervical cancer screening. JCO Global Oncology, 10, 450–462.